Table 1.
12 h |
24 h |
|||
Control | Buprenorphine | Control | Buprenorphine | |
Plasma | ||||
IL6 | 10.51 ± 14.39 | 10.92 ± 18.99 | 3.15 ± 6.22 | 1.73 ± 2.47 |
IL10 | 5.00 ± 7.20 | 4.80 ± 7.92 | 1.97 ± 2.97 | 0.96 ± 1.29 |
CXCL1/KC | 0.24 ± 0.31 | 0.21 ± 0.33 | 39.28 ± 65.11 | 26.44 ± 44.29 |
CXCL2/MIP2α | 0.33 ± 0.33 | 0.29 ± 0.28 | 3.04 ± 3.93 | 2.10 ± 3.33 |
Peritoneum | ||||
IL6 | 8.39 ± 7.49 | 8.64 ± 8.89 | 1.11 ± 2.42 | 1.05 ± 1.99 |
IL10 | 0.96 ± 1.10 | 0.83 ± 0.93 | 0.64 ± 0.74 | 0.47 ± 0.54 |
CXCL1/KC | 0.03 ± 0.03 | 0.03 ± 0.04 | 3.74 ± 6.12 | 5.35 ± 11.82 |
CXCL2/MIP2α | 0.08 ± 0.04 | 0.07 ± 0.05 | 0.57 ± 0.60 | 0.76 ± 1.50 |